Ocumension Therapeutics (HKG:1477)
Hong Kong · Delayed Price · Currency is HKD 8.25
+0.09 (1.10%)
Apr 17, 2026, 3:28 PM HKT
Ocumension Therapeutics Market Cap
Ocumension Therapeutics has a market cap or net worth of 6.65 billion as of April 16, 2026. Its market cap has increased by 61.71% in one year.
Market Cap
6.65B
Enterprise Value
6.41B
Revenue
895.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.25
Market Cap Chart
Since July 10, 2020, Ocumension Therapeutics's market cap has decreased from 21.28B to 6.65B, a decrease of -68.74%. That is a compound annual growth rate of -18.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 6.65B | 10.27% |
| Dec 31, 2025 | 6.03B | 64.39% |
| Dec 31, 2024 | 3.67B | -20.44% |
| Dec 29, 2023 | 4.61B | -30.21% |
| Dec 30, 2022 | 6.61B | -43.35% |
| Dec 31, 2021 | 11.67B | -26.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guangzhou Innogen Pharmaceutical Group | 9.42B |
| Shanghai Haohai Biological Technology | 9.32B |
| Abbisko Cayman | 9.12B |
| Laekna | 7.11B |
| CK Life Sciences Int'l., (Holdings) | 7.02B |
| Jacobio Pharmaceuticals Group | 6.28B |
| Beijing Luzhu Biotechnology | 4.41B |
| Shandong Boan Biotechnology | 4.41B |